Patents by Inventor James A. Flanders

James A. Flanders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11903976
    Abstract: Disclosed are an implantable therapeutic delivery system and methods of treatment utilizing the implantable therapeutic delivery system. The implantable therapeutic delivery system includes a nanofibrous core substrate including one or more internal spaces wherein one or more therapeutic agents is positioned in the one or more internal spaces; and an outer biocompatible polymeric coating surrounding said nanofibrous core substrate.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: February 20, 2024
    Assignee: CORNELL UNIVERSITY
    Inventors: Minglin Ma, James A. Flanders, Duo An
  • Patent number: 10493107
    Abstract: The present invention relates to an implantable therapeutic delivery system, methods of treatment utilizing the implantable therapeutic delivery system, and methods of fabricating the implantable delivery system. A first aspect of the present invention is directed to an implantable therapeutic delivery system. This therapeutic delivery system comprises a substrate, an inner polymeric coating that surrounds the substrate, and an outer hydrogel coating that surrounds said inner polymeric coating. One or more therapeutic agents are positioned in the outer hydrogel coating.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: December 3, 2019
    Assignee: CORNELL UNIVERSITY
    Inventors: Minglin Ma, James A. Flanders, Duo An
  • Publication number: 20150073045
    Abstract: The invention relates to a novel compound of the formula or pharmaceutically acceptable salts thereof as well as pharmaceutical, nutraceutical, and botanical drug compositions and therapeutic methods related thereto. In certain embodiments, the compounds are used for the treatment of abnormal cell growth, hyperproliferative disorders, and inflammatory diseases in mammals. In other embodiments, the invention encompasses methods to isolate and synthesize the compounds.
    Type: Application
    Filed: November 17, 2014
    Publication date: March 12, 2015
    Applicant: CORNELL UNIVERSITY
    Inventors: Kathryn J. Chavez, Eloy Rodriguez, Frank Schroeder, James A. Flanders
  • Publication number: 20140128458
    Abstract: The invention relates to a novel compound of the formula or pharmaceutically acceptable salts thereof as well as pharmaceutical, nutraceutical, and botanical drug compositions and therapeutic methods related thereto. In certain embodiments, the compounds are used for the treatment of abnormal cell growth, hyperproliferative disorders, and inflammatory diseases in mammals. In other embodiments, the invention encompasses methods to isolate and synthesize the compounds.
    Type: Application
    Filed: October 1, 2013
    Publication date: May 8, 2014
    Applicant: CORNELL UNIVERSITY
    Inventors: Kathryn J. Chavez, Eloy Rodriguez, Frank Schroeder, James A. Flanders
  • Patent number: 8563603
    Abstract: The invention relates to a novel compound of formula I or pharmaceutically acceptable salts thereof as well as pharmaceutical, nutraceutical, and botanical drug compositions and therapeutic methods related thereto. In certain embodiments, the compounds are used for the treatment of abnormal cell growth, hyperproliferative disorders, and inflammatory diseases in mammals. In other embodiments, the invention encompasses methods to isolate and synthesize the compounds.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: October 22, 2013
    Assignee: Cornell University
    Inventors: Kathryn J. Chavez, Eloy Rodriguez, Frank Schroeder, James A. Flanders
  • Publication number: 20110275708
    Abstract: The invention relates to a novel compound of formula I or pharmaceutically acceptable salts thereof as well as pharmaceutical, nutraceutical, and botanical drug compositions and therapeutic methods related thereto. In certain embodiments, the compounds are used for the treatment of abnormal cell growth, hyperproliferative disorders, and inflammatory diseases in mammals. In other embodiments, the invention encompasses methods to isolate and synthesize the compounds.
    Type: Application
    Filed: October 22, 2009
    Publication date: November 10, 2011
    Applicant: CORNELL UNIVERSITY
    Inventors: Kathryn J. Chavez, Eloy Rodriguez, Frank Schroeder, James A. Flanders